Fri, 13 Nov, 2026, 09:03 am
New RNA Switch Could Make Gene Therapies Safer and More Controllable
Reported by today.ucsd.edu
Bioengineers at the University of California San Diego have developed a technology that allows drugs to control when cells produce therapeutic proteins, which could potentially make gene therapies safer and more adaptable for treating chronic diseases.
The technology could help address a longstanding challenge in gene therapy: how to provide long-lasting treatment without allowing therapeutic proteins to remain active at potentially harmful levels. In preclinical studies, researchers used the approach to activate production of a protein that helped reverse obesity and fat buildup in the liver.
Gene therapies work by delivering genetic instructions that tell cells to make a therapeutic protein. But once those instructions are delivered, it can be difficult to control how much protein cells produce and for how long. Some proteins are beneficial only within a narrow range. Too little may not treat the disease, while too much or prolonged exposure can cause harmful side effects.